Your browser doesn't support javascript.
loading
Objectively Measured Physical Activity in Patients with COPD: Recommendations from an International Task Force on Physical Activity.
Demeyer, Heleen; Mohan, Divya; Burtin, Chris; Vaes, Anouk W; Heasley, Matthew; Bowler, Russell P; Casaburi, Richard; Cooper, Christopher B; Corriol-Rohou, Solange; Frei, Anja; Hamilton, Alan; Hopkinson, Nicholas S; Karlsson, Niklas; Man, William D-C; Moy, Marilyn L; Pitta, Fabio; Polkey, Michael I; Puhan, Milo; Rennard, Stephen I; Rochester, Carolyn L; Rossiter, Harry B; Sciurba, Frank; Singh, Sally; Tal-Singer, Ruth; Vogiatzis, Ioannis; Watz, Henrik; Lummel, Rob Van; Wyatt, Jeremy; Merrill, Debora D; Spruit, Martijn A; Garcia-Aymerich, Judith; Troosters, Thierry.
Afiliação
  • Demeyer H; Department of Rehabilitation Sciences, KU Leuven-University of Leuven and Respiratory Division, University Hospitals Leuven, Leuven, Belgium.
  • Mohan D; Department of Rehabilitation Sciences, Ghent University, Ghent, Belgium.
  • Burtin C; Medical Innovation, Value Evidence and Outcomes, GlaxoSmithKline Research and Development, Collegeville, Pennsylvania, United States.
  • Vaes AW; Reval Rehabilitation Research Center, Biomed Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
  • Heasley M; Department of Research and Development, CIRO, Horn, Netherlands.
  • Bowler RP; Digital Biomarkers, GlaxoSmithKline Research and Development, Stevenage, United Kingdom.
  • Casaburi R; National Jewish Health, Denver, Colorado, United States.
  • Cooper CB; Rehabilitation Clinical Trials Center, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States.
  • Corriol-Rohou S; Departments of Medicine and Physiology, David Geffen School of Medicine, University of California, Los Angeles, California, United States.
  • Frei A; AstraZeneca Research and Development, Global Regulatory Excellence, Paris, France.
  • Hamilton A; Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
  • Hopkinson NS; Boehringer Ingelheim Canada, Burlington, Ontario, Canada.
  • Karlsson N; National Heart and Lung Institute, Imperial College, London, United Kingdom.
  • Man WD; Respiratory Medicine, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.
  • Moy ML; BioPharmaceuticals Research and Development Digital Health, AstraZeneca, Gothenburg, Sweden.
  • Pitta F; National Heart and Lung Institute, Imperial College, London, United Kingdom.
  • Polkey MI; Harefield Respiratory Research Group, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.
  • Puhan M; Pulmonary, Critical Care, and Sleep Medicine Section, VA Boston Healthcare System, Boston, Massachusetts, United States.
  • Rennard SI; Harvard Medical School, Boston, Massachusetts, United States.
  • Rochester CL; Laboratory of Research in Respiratory Physiotherapy, State University of Londrina, Brazil.
  • Rossiter HB; National Heart and Lung Institute, Imperial College, London, United Kingdom.
  • Sciurba F; Respiratory Medicine, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.
  • Singh S; Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
  • Tal-Singer R; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, United States.
  • Vogiatzis I; Section of Pulmonary, Critical Care and Sleep, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States.
  • Watz H; VA Connecticut Healthcare System, West Haven, Connecticut, United States.
  • Lummel RV; Rehabilitation Clinical Trials Center, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States.
  • Wyatt J; Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.
  • Merrill DD; Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pennsylvania, United States.
  • Spruit MA; Department of Respiratory Science, University of Leicester, Leicester, United Kingdom.
  • Garcia-Aymerich J; COPD Foundation, COPD360 Research, Miami, Florida, United States.
  • Troosters T; Department of Sport, Exercise, and Rehabilitation, Northumbria University, Newcastle, United Kingdom.
Chronic Obstr Pulm Dis ; 8(4): 528-550, 2021 Oct 28.
Article em En | MEDLINE | ID: mdl-34433239
Physical activity (PA) is of key importance for health among healthy persons and individuals with chronic obstructive pulmonary disease (COPD). PA has multiple dimensions that can be assessed and quantified objectively using activity monitors. Moreover, as shown in the published literature, variable methodologies have been used to date to quantify PA among individuals with COPD, precluding clear comparisons of outcomes across studies. The present paper aims to provide a summary of the available literature for the rationale behind using objectively measured PA and proposes a standardized methodology for assessment, including standard operating procedures for future research. The present paper, therefore, describes the concept of PA, reports on the importance of PA, summarizes the dimensions of PA, provides a standard operating procedure on how to monitor PA using objective assessments, and describes the psychometric properties of objectively measured PA. The present international task force recommends implementation of the standard operating procedure for PA data collection and reporting in the future. This should further clarify the relationship between PA and clinical outcomes, test the impact of treatment interventions on PA in individuals with COPD, and successfully propose a PA endpoint for regulatory qualification in the future.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Chronic Obstr Pulm Dis Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Bélgica

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Chronic Obstr Pulm Dis Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Bélgica